SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to a recently announced NFL apparel partnership with Fanatics, marking the brand's first foray into officially licensed NFL merchandise and expanding its reach into team sports apparel. The community is actively discussing the potential for Super Bowl ads and further collaborations, while some investors are speculating about a potential activist campaign led by founder Chip Wilson to shake up leadership. Despite positive news, concerns linger around tariffs and the company's growth strategy amid a broader market downturn.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending amid discussions about a potential acquisition of Larvotto Resources and its significance for securing antimony supply, essential for defense and technology. Community members are weighing the implications of the deal, while some point to JP Morgan's investment in a competitor as a catalyst for sector-wide interest in antimony production. Despite recent price volatility and a rejected initial offer, the focus remains on UAMY's strategic position as a key domestic supplier.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as it unveils new AI chips targeting the data center market, aiming to compete with Nvidia and AMD. The community is discussing the potential impact of this move on the semiconductor landscape, with some anticipating significant growth for Qualcomm while others suggest increased competition may signal a sector cooldown. Bullish sentiment appears to be fueled by raised price targets and anticipation of a breakthrough in the AI chip world.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia is trending downwards following a self-imposed pause in late-stage clinical trials due to liver enzyme elevations in a patient, sparking community debate about the severity and implications of the event. Some investors view the dip as a buying opportunity, citing the potential for trial resumption and the company's long-term prospects in gene editing, while others are concerned about the potential impact on the company's future.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics is trending amid discussions about its partnership with the Vegas Golden Knights and anticipation for its humanoid robot reveal at the NVIDIA GTC conference. Community chatter revolves around potential breakthroughs in AI and robotics, as well as speculation about the company's long-term growth and partnerships. Some traders express concerns about short-term volatility and potential dilution, while others remain optimistic about Richtech's role in the future of service robotics.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the OG meme coin, emphasizing its cultural significance and a return to the 'trenches' of meme creation. Community members express strong conviction and belief in the project, highlighting its organic growth and potential to disrupt the industry. The focus remains on community, memes, and shared enthusiasm.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid excitement surrounding new all-time highs and a recent partnership to deploy AI with Lumen Technologies, sparking discussions about the company's role in AI infrastructure. The community is buzzing about the potential for further gains and upcoming earnings, while some express concerns about valuation. Government contracts and ties are also a key talking point.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as chatter revolves around a Trump Jr.-linked drone company securing a Pentagon contract and community members are actively discussing the implications of this contract, along with future targets based on chart analysis. Some traders are speculating on the potential for further government contracts and the overall heating up of the drone sector, while others point to the company's connection to the Trump family as a source of both opportunity and concern. Community members are closely watching for news and volume expansion that could force chasers through resistance levels.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending as the community discusses its recent price volatility and potential for a rebound, with some speculating about manipulation and others pointing to strong fundamentals. Bullish investors highlight the company's unique product and substantial revenue growth, while others express concern about potential dilutions and the stock's trading patterns. The company addressed the volatility with a statement noting no undisclosed material changes.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending due to its upcoming PDUFA date for Revuforj, with community members weighing in on the potential FDA decision and its impact on the stock. Discussions include the drug's market potential, comparisons to competitor KURA, and speculation about a potential buyout. Some traders are also highlighting the high short interest and potential for a squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 43.7% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Investors Undervaluing Omnicell (OMCL) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last?

10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL vs. HIMS: Which Stock Is the Better Value Option?

NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings

NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.

Is Omnicell (OMCL) Stock Undervalued Right Now?

Reasons to Add Omnicell Stock to Your Portfolio Right Now

OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.

BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience

BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Omnicell, Inc.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$30.94
Prev Close	$31.10
Open	$31.22
Dividend Yield	0.00%
50-Day Moving Average	$31.42
Beta	1.16
Avg. Volume	503,100.00
PE Ratio	63.04

52-Week High	$55.75
52-Week Low	$22.66
Market Capitalization	$1.43B
EPS (Annual)	$0.2709
Price to Book	1.14
Revenue Per Employee	$303,062.13
Enterprise Value/EBITDA	N/A

OMCL
Omnicell, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OMCL News

OMCLOmnicell, Inc.